These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 29588398

  • 1. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398
    [Abstract] [Full Text] [Related]

  • 2. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
    Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG.
    PLoS One; 2015 Mar 27; 10(2):e0116381. PubMed ID: 25658638
    [Abstract] [Full Text] [Related]

  • 3. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS, Tepp WH, Bradshaw M, Johnson EA, Pellett S.
    mSphere; 2018 Oct 24; 3(5):. PubMed ID: 30355669
    [Abstract] [Full Text] [Related]

  • 4. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR, Rees J, Liu SM, Acharya KR.
    J Struct Biol; 2018 May 24; 202(2):113-117. PubMed ID: 29288126
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.
    Leka O, Wu Y, Li X, Kammerer RA.
    J Biol Chem; 2021 May 24; 296():100684. PubMed ID: 33891946
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
    Kroken AR, Blum FC, Zuverink M, Barbieri JT.
    Infect Immun; 2017 Jan 24; 85(1):. PubMed ID: 27795365
    [Abstract] [Full Text] [Related]

  • 8. In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5.
    Pellett S, Tepp WH, Whitemarsh RC, Bradshaw M, Johnson EA.
    Toxicon; 2015 Dec 01; 107(Pt A):37-42. PubMed ID: 26130522
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
    Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, Barbieri JT.
    Biochemistry; 2009 Mar 24; 48(11):2522-8. PubMed ID: 19256469
    [Abstract] [Full Text] [Related]

  • 11. Purification and characterization of a novel subtype a3 botulinum neurotoxin.
    Tepp WH, Lin G, Johnson EA.
    Appl Environ Microbiol; 2012 May 24; 78(9):3108-13. PubMed ID: 22367089
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 15. How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane.
    Gardner AP, Barbieri JT, Pellett S.
    Toxins (Basel); 2022 Nov 22; 14(12):. PubMed ID: 36548711
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.
    Whitemarsh RC, Tepp WH, Bradshaw M, Lin G, Pier CL, Scherf JM, Johnson EA, Pellett S.
    Infect Immun; 2013 Oct 22; 81(10):3894-902. PubMed ID: 23918782
    [Abstract] [Full Text] [Related]

  • 18. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C, Avril A, Chahboun S, Tierney R, Bak N, Miethe S, Mazuet C, Popoff MR, Thullier P, Hust M, Pelat T, Sesardic D.
    MAbs; 2015 Oct 22; 7(6):1161-77. PubMed ID: 26381852
    [Abstract] [Full Text] [Related]

  • 19. Botulinum neurotoxin X lacks potency in mice and in human neurons.
    Gregg BM, Matsumura T, Wentz TG, Tepp WH, Bradshaw M, Stenmark P, Johnson EA, Fujinaga Y, Pellett S.
    mBio; 2024 Mar 13; 15(3):e0310623. PubMed ID: 38347673
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.
    Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, Bruce DC, Doggett NA, Smith LA, Marks JD, Xie G, Brettin TS.
    PLoS One; 2007 Dec 05; 2(12):e1271. PubMed ID: 18060065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.